SCHEMBL10924682

SCHEMBL10924682

CC(=O)n1c(CBr)c(C(N)=O)n(C(C)=O)c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10877012 0.85 — —
SCHEMBL10971128 0.84 — —
SCHEMBL5228776 0.82 TRPA1 (0.33) —
SCHEMBL10924646 0.79 — —
SCHEMBL14533300 0.79 — —
SCHEMBL10925377 0.79 — —
SCHEMBL10656393 0.77 HPGD (0.39) —
SCHEMBL10965641 0.76 NPC1 (0.32) —
SCHEMBL10967786 0.73 MEN1 (0.30) —
SCHEMBL10652691 0.70 ABL1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0064705-B1 5-AMINOMETHYL-2,3-DIHYDRO-2-OXO-1H-IMIDAZOLE-4-CARBOXYLIC ACID DERIVATIVES MERRELL DOW PHARMACEUTICALS INC. (US) 1986-06-18 — — EP disclosed
EP-0064706-B1 5-(4-PHENYL-1-PIPERIDINYL)METHYL-2,3-DIHYDRO-2-OXO-1H-IMIDAZOLE-4-CARBOXYLIC ACID DERIVATIVES MERRELL DOW PHARMACEUTICALS INC. (US) 1985-07-03 — — EP disclosed
US-4371737-A CARDIOTONICS, ANTIHYPERTENSIUES AND ANTITHROMBOTIC AGENTS MERRELL DOW PHARMACEUTICALS INC. (US) 1983-02-01 — — US disclosed
EP-0064706-A1 5-(4-Phenyl-1-piperidinyl)methyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1982-11-17 — — EP disclosed
EP-0064705-A1 5-Aminomethyl-2,3-dihydro-2-oxo-1H-imidazole-4-carboxylic acid derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1982-11-17 — — EP disclosed
US-4329470-A CORDIOTONIC, HYPOTENSIVE, ANTITHROMBOSIS MERRELL DOW PHARMACEUTICALS INC. (US) 1982-05-11 — — US disclosed
Send feedback